Company Name, Ticker, Customers, else..
STOCKS
HOME
Stock Profile
Company Fundamentals
Financial Results
CPHI's Officers & Directors
Company Descriptions
Charts & Quotes
News
Company Suppliers
Company Competitors
Company Markets Customers
Economic Indicators
INDUSTRIES
Revenue Growth by Industry
Net Income Growth by Industry
Net Margin by Industry
PE by Industry
Total Debt to Equity by Industry
Revenue per Employee by Industry
Return On Assets by Industry
Performance by Industry
Growth Rates by Industry
Profitability by Industry
Valuation by Industry
Financial Strength by Industry
ECONOMY
Advance Monthly Sales
Consumer Price Index CPI
Producer Price Index PPI
Retail Inventories
Personal Income
Gross Domestic Product GDP
Money Supply
Industrial Production
Productivity
Employment Situation
U.S. International Trade
Factory orders
Durable Goods
Construction Spending
Housing Starts
Vehicle Unit Sales
MARKETS
Stocks
Cryptocurrencies
Sectors & Industries
Commodities
Foreign Exchange
Stocks in 2023
SCREENING
Stock Performance Screening
Profitability Screening
Valuation Screening
Dividend Screening
Financial Strength Screening
Efficiency Screening
Largest Companies
Mgmnt. Effectivness Screening
NEWS
Stock News
Economy News
GLOSSARY
Financial Terms
Technical Analysis
Fundamental Analysis
Energy Terms
Manufacturing Terms
Transportation Terms
Health Care
Insurance Terms
Economy Terms
Hotel & Leisure Terms
HELP
Company Profile
China Pharma Holdings Inc News
China Pharma Holdings Inc's Price to sales ratio PS
China Pharma Holdings Inc's ROA
China Pharma Holdings Inc Business Description
China Pharma Holdings Inc Executive Officers
Economic Indicators
Fundamentals
China Pharma Holdings Inc Growth Rates
China Pharma Holdings Inc Profitability
China Pharma Holdings Inc Valuation
China Pharma Holdings Inc Management Effectiveness
China Pharma Holdings Inc Financial Strength
China Pharma Holdings Inc Efficiency
China Pharma Holdings Inc Dividend
Financials
China Pharma Holdings Inc Business Segments
China Pharma Holdings Inc Income Statement
China Pharma Holdings Inc Balance Sheets
China Pharma Holdings Inc Cash Flow Statement
China Pharma Holdings Inc Geographic Information
Suppliers
China Pharma Holdings Inc Suppliers Performance
CPHI Suppliers Stock Performance
CPHI Suppliers Growth Rates
CPHI Suppliers Data
CPHI Suppliers Efficiency
CPHI Suppliers Management Effectiveness
CPHI Suppliers Valuation
CPHI Suppliers by Companys' Segments
Competition
Competition by Companys' Segments
China Pharma Holdings Inc Market Share
China Pharma Holdings Inc Competition Performance
China Pharma Holdings Inc Competitors Results
CPHI Competitors Stock Performance
CPHI Competitors Growth Rates
CPHI Workforce Efficiency at the Competitors
CPHI Competitors Efficiency
CPHI Competitors Management Effectiveness
CPHI Competitors Valuation
Customers & Markets
China Pharma Holdings Inc Customers Demand
CPHI Customers Expenditure Growth Rates
CPHI Customers Performance
CPHI Customers Stock Performance
CPHI Customers Growth Rates
CPHI Workforce Efficiency at the Customers
CPHI Customers Efficiency
CPHI Customers Management Effectiveness
CPHI Customers Valuation
CPHI Customers by Companys' Segments
Charts & Quotes
China Pharma Holdings Inc Comparison Charts
CPHI OHLC Charts
CPHI's Tehnical Upper Indicators
CPHI's Tehnical Lower Indicators
CPHI's Weekly Charts
CPHI's Monthly Charts
China Pharma Holdings Inc's Profile
Company Charts and Quotes
China Pharma Holdings Inc News
China Pharma Holdings Inc's Geographic Information
China Pharma Holdings Inc's Income Statement
China Pharma Holdings Inc's Balance Sheets
China Pharma Holdings Inc's Cash Flow Statement
China Pharma Holdings Inc's Profitability
China Pharma Holdings Inc's Financials
China Pharma Holdings Inc's Free Cash Flow Margin
China Pharma Holdings Inc's Suppliers
China Pharma Holdings Inc's Competitors
China Pharma Holdings Inc's Markets & Customers
China Pharma Holdings Inc's Market Share
CPHI's Suppliers Valuation
CPHI's Employee Efficiency at the Competitors
OHLC
China Pharma Holdings Inc's Customers Expenditure Growth Rates
Economic Indicators
Industry Valuation
List of the Largest Companies
Markets at a Glance
Stocks
Cryptocurrencies
Sectors & Industries
Commodities
Foreign Exchange
Stocks in 2023
Advance Monthly Sales
News
Economy News
Stock News
Transportation Terms
At a Glance
Growth Rates
• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• OP. Inc. Y/Y Annual
Profitability
Valuation Comparisons
Management Effectiveness
Financial Strength
Efficiency
Dividend Comparisons
China Pharma Holdings Inc
(
CPHI
)
Other Ticker:
Sector
•
Healthcare
Industry
•
Major Pharmaceutical Preparations
Industry
•
Major Pharmaceutical Preparations
Sector
•
Healthcare
China Pharma Holdings Inc 's Yearly Operating Income Growth 5 Years
Select the Comparisons :
None ▼
Growth Rates
Profitability
Valuation Comparisons
Management Effectiveness
Financial Strength
Efficiency
Dividend Comparisons
Select the Ratio:
Annual Operating Income Annual Growth Rates Y/Y▼
Revenue Y/Y
Op. Income Y/Y
Income from Cont. Operations Y/Y
Net Income Y/Y
Effective Tax Rate
Eps Cop. Y/Y
Eps Net Y/Y
Free Cash Flow Y/Y
Cash Flow Y/Y
Capex Y/Y
Gross Margin
EBITDA Margin
Operating Margin
Net Margin
Pre-Tax Margin
Free Cash Flow Margin
Cash Flow Margin
P/E Ratio TTM
P/S Ratio TTM
P/CF Ratio TTM
P/FCF Ratio TTM
Price to Book MRQ
Price to Tangible Book
ROA Quarterly
ROI Quarterly
ROE Quarterly
Quick Ratio
Quick Ratio TTM
Working Capital
Working Capital TTM
Long Term Debt to Equity
Long Term Debt to Equity TTM
Debt to Equity
Debt to Equity TTM
Leverage Ratio
Leverage Ratio TTM
Tangible Leverage Ratio
Interest Coverage
Debt Coverage
Working Capital Per Revenue
Sales per Employee
Income per Employee
Inventory to Sales
Inventory Turnover
Asset Turnover
Receivables Turnover
Dividend Growth
Dividend Payout
Cumulative Payout
Annual Dividend Payout
Revenue Annual Growth
Operating Income Annual Growth
Income from Continued Operations Annual Growth
Net Income Annual Growth
Eps Continued Operations Annual Growth
Eps Net Annual Growth
Free Cash Flow Annual Growth
Cash Flow Annual Growth
Capex Annual Growth
None ▼
Growth Rates
Profitability
Valuation Comparisons
Management Effectiveness
Financial Strength
Efficiency
Dividend Comparisons
Annual Operating Income Annual Growth Rates Y/Y▼
Revenue Y/Y
Op. Income Y/Y
Income from Cont. Operations Y/Y
Net Income Y/Y
Effective Tax Rate
Eps Cop. Y/Y
Eps Net Y/Y
Free Cash Flow Y/Y
Cash Flow Y/Y
Capex Y/Y
Gross Margin
EBITDA Margin
Operating Margin
Net Margin
Pre-Tax Margin
Free Cash Flow Margin
Cash Flow Margin
P/E Ratio TTM
P/S Ratio TTM
P/CF Ratio TTM
P/FCF Ratio TTM
Price to Book MRQ
Price to Tangible Book
ROA Quarterly
ROI Quarterly
ROE Quarterly
Quick Ratio
Quick Ratio TTM
Working Capital
Working Capital TTM
Long Term Debt to Equity
Long Term Debt to Equity TTM
Debt to Equity
Debt to Equity TTM
Leverage Ratio
Leverage Ratio TTM
Tangible Leverage Ratio
Interest Coverage
Debt Coverage
Working Capital Per Revenue
Sales per Employee
Income per Employee
Inventory to Sales
Inventory Turnover
Asset Turnover
Receivables Turnover
Dividend Growth
Dividend Payout
Cumulative Payout
Annual Dividend Payout
Revenue Annual Growth
Operating Income Annual Growth
Income from Continued Operations Annual Growth
Net Income Annual Growth
Eps Continued Operations Annual Growth
Eps Net Annual Growth
Free Cash Flow Annual Growth
Cash Flow Annual Growth
Capex Annual Growth
CPHI Annual Operating Income Growth
2022
2021
2020
2019
2018
Y / Y Annual Operating Income Change
-
-
-
-
-
Annual Operating Income (in millions $)
$-3.55
$-2.86
$-2.58
$-20.41
$-10.45
CPHI Company Profile
>>
Back to CPHI Fundamentals at a Glance
>>
Back to CPHI Growth Comparisons
Annual Operating Income Growth Comment
China Pharma Holdings Inc
realized Operating Loss.
China Pharma Holdings Inc Annual Income Statement
You need to upgrade your Flash Player
Companies with similar 2022 Annual Operating Income within Healthcare Sector
Y/Y Operating Income Growth %
2022 Annual Operating Income
Organogenesis Holdings Inc
-69.41 %
$ 22.304 millions
Vyne Therapeutics Inc